MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Dual-Task Cost of Walking While Using a Smartphone: A Comparison Study of Older Adults with and Without Cognitive Decline

    G. Christofoletti, T. Lino, S. Sobrinho Junior (Campo Grande, Brazil)

    Objective: To investigate spatiotemporal gait parameters in older adults with and without cognitive decline while walking in the presence of smartphone use. Background: The use…
  • 2024 International Congress

    Cognitive, Non-Motor, and Quality of Life Outcomes After STN or GPi DBS for Parkinson’s Disease: An Interim Report from the ADROIT NAPA Sub-Study

    M. Potter-Nerger, A. Gharabaghi, C. Torres Diaz, A. Schnitzler, S. Chen, L. Himes, M. Frassica, D. Nanduri, S. Groppa (Hamburg, Germany)

    Objective: To summarize the effect of subthalamic nucleus (STN) or globus pallidus internus (GPi) DBS on cognition, quality of life, and non-motor symptoms in patients…
  • 2024 International Congress

    How Does Mild Cognitive Impairment in Parkinson’s Disease Affect Communication Abilities?

    F. Rodriguez-Porcel, T. Turner (Charleston, USA)

    Objective: We explored differences in communication abilities in people with Parkinson’s disease (PwP) with mild cognitive impairment (MCI) (PwP-MCI) and those with normal cognition (PwP-CN).…
  • 2024 International Congress

    Clinical and Neuroimaging Biomarker Predictors of Cognitive Dysfunction In Parkinson’s Disease: A Study Using PPMI Data

    M. Schlindwein, A. Franco, J. Catao, D. Teixeira-Dos-Santos, A. Bieger, T. Hugentobler Schlickmann, L. Angi Souza, C. Mattjie, F. Suzuki, G. Magalhães Pereira, L. Silveira Kupssinskü, L. Vinícius Moura, R. Ravazio, S. Duarte Pinto, M. Bastiani, R. Barros, E. R. Zimmer, A. Schuh (Porto Alegre, Brazil)

    Objective: This study evaluates whether clinical, biological, and neuroimaging baseline markers can predict the onset of significant cognitive-based milestones developed in these cohorts over a…
  • 2024 International Congress

    Apathy produces selective deficits in cognitive function when controlling for depression in patients with Parkinson’s disease

    G. Badwal, K. Patel, S. Pasternak, H. Ganjavi, R. Renwick, R. Camicioli, K. van Hedger, P. Macdonald (London, Canada)

    Objective: To compare differences in the mean cognitive impairment (CI) of patients with and without clinically significant apathy in PD, PD-mild cognitive impairment (PD-MCI), and…
  • 2024 International Congress

    Cognitive Reserve and Motor Subtypes of Parkinson’s Disease

    A. Deleón Pérez, S. Castillo Torres, J. Trejo Ayala, I. Estrada Bellmann, B. Chávez Luévanos, P. Téllez Hernández, D. Ortiz Zacarias (Monterrey, Mexico)

    Objective: To assess differences in cognitive reserve (CR) between motor subtypes of patients with Parkinson’s disease (PD). Background: Motor subtypes in patients with PD have…
  • 2024 International Congress

    Clinical and neurological features of the course of Parkinsonism disease in patients with CKD with cystatin C disorder

    S. Khudayarova, G. Rakhmatullayeva (Tashkent, Uzbekistan)

    Objective: To study the effect of cystatin C on the development of cognitive disorders(CD) in patients with CKD(Chronic kidney disease) and vascular parkinsonism Background: Clinical…
  • 2024 International Congress

    Orthostatic Hypotension is Associated with Worse Verbal Letter Fluency and Lower Neural Efficiency While Upright in Parkinson’s Disease: A Pilot Study

    K. Longardner, P. Reddy, K. Izzetoglu, I. Litvan (SAN DIEGO, USA)

    Objective: To evaluate positional effects on cognitive performance and cerebral hemodynamics in Parkinson’s disease (PD) patients with and without orthostatic hypotension (OH). Background: OH is…
  • 2024 International Congress

    Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) on Activities of Daily Living, Behavioural and Cognitive ability (A-B-C) of PD Patients: A Randomized Controlled Trial

    R. Makkar, R. Hazrati, A. Nehra (Ghaziabad, India)

    Objective: The aim of the RCT was to study the effectiveness of rTMS on the activities of daily living, behavioural and cognitive ability (A-B-C) of…
  • 2024 International Congress

    The impact of cognitive impairment and Alzheimer’s disease neuropathological changes on gait and falls in Parkinson’s disease

    J. Parmera, P. Cullinane, S. Wrigley, T. Revesz, Z. Jaunmuktane, T. Warner, E. de Pablo-Fernandez (London, United Kingdom)

    Objective: To investigate the association between clinical markers of cognitive impairment, severity, and distribution of Alzheimer's disease neuropathological changes (ADNC) with gait difficulties, freezing of…
  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley